Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

[IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases].

Yehudai D, Vadasz Z.

Harefuah. 2012 Mar;151(3):171-4, 188. Review. Hebrew.

PMID:
22519268
3.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

Sibéril S, Elluru S, Negi VS, Ephrem A, Misra N, Delignat S, Bayary J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Transfus Apher Sci. 2007 Aug;37(1):103-7. Epub 2007 Aug 31. Review.

PMID:
17765663
4.

Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.

Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, Bacchi-Reggiani L, Pacini D.

J Cardiothorac Vasc Anesth. 2005 Aug;19(4):440-5.

PMID:
16085247
5.

Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis.

Akdag A, Dilmen U, Haque K, Dilli D, Erdeve O, Goekmen T.

Am J Perinatol. 2014 Nov;31(10):905-12. doi: 10.1055/s-0033-1363771. Epub 2014 Feb 10.

PMID:
24515621
6.

Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis.

Haque KN, Remo C, Bahakim H.

Clin Exp Immunol. 1995 Aug;101(2):328-33.

7.
8.

High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Ishii N, Hashimoto T, Zillikens D, Ludwig RJ.

Clin Rev Allergy Immunol. 2010 Apr;38(2-3):186-95. doi: 10.1007/s12016-009-8153-y. Review.

PMID:
19557317
9.

[Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].

Mouthon L, Hurez V, Kazatchkine M.

Ann Med Interne (Paris). 1993;144(8):506-13. Review. French.

PMID:
8179238
10.

Intravenous immunoglobulin therapy for autoimmune diseases.

Arnson Y, Shoenfeld Y, Amital H.

Autoimmunity. 2009 Sep;42(6):553-60. doi: 10.1080/08916930902785363. Review.

PMID:
19657774
11.

Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation.

Bar-Dayan Y, Bonnin E, Bloch M, Schweitzer R, Ravid M, Kazatchkine MD, Kaveri SV.

Scand J Immunol. 2000 Apr;51(4):408-14.

12.

Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.

Mouthon L, Kaveri S, Kazatchkine M.

Transfus Sci. 1994 Dec;15(4):393-408. Review.

PMID:
10155557
13.

Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.

Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, Kaveri SV.

J Clin Immunol. 2010 May;30 Suppl 1:S4-8. doi: 10.1007/s10875-010-9394-5. Review.

PMID:
20405183
14.

To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.

Neugebauer EA.

Crit Care Med. 2007 Dec;35(12):2855-6. No abstract available.

PMID:
18043203
15.

[Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].

Graff-Dubois S, Sibéril S, Elluru S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayary J, Kaveri SV.

Transfus Clin Biol. 2007 May;14(1):63-8. Epub 2007 May 10. Review. French.

PMID:
17498995
16.

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.

Ballow M.

J Allergy Clin Immunol. 2011 Feb;127(2):315-23; quiz 324-5. doi: 10.1016/j.jaci.2010.10.030. Epub 2010 Dec 24. Review.

PMID:
21185071
17.

Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.

Hurez V, Kaveri SV, Kazatchkine MD.

J Autoimmun. 1993 Dec;6(6):675-81. Review.

PMID:
8155249
18.

Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.

Wong PH, White KM.

Clin Rev Allergy Immunol. 2016 Dec;51(3):303-314. Review.

PMID:
26142065
19.

High dose intravenous immunoglobulin treatment: mechanisms of action.

Boros P, Gondolesi G, Bromberg JS.

Liver Transpl. 2005 Dec;11(12):1469-80. Review.

20.

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD.

Neurol Sci. 2003 Oct;24 Suppl 4:S217-21. Review.

PMID:
14598046

Supplemental Content

Support Center